Introduction
With the increasing use of dialysis treatment for both acute and chronic renal failure complications of this therapy are being widely recognized. One such complication is the removal of water-soluble vitamins from the patient's blood by the dialysis. Palmer et al. (1966) suggested that this could occur as part of a general " depletion syndrome " in patients having long-term peritoneal dialysis, and Wernicke's encephalopathy has been described in one patient (Clinicopathological Conference, 1966) . Lasker et al. (1963) demonstrated low plasma levels of folate and nicotinic acid in uraemic patients but failed to show any significant changes in the levels of these substances or in the levels of other vitamins during either peritoneal dialysis or haemodialysis. Nevertheless, Hampers et al. (1967) described megaloblastic hacmopoiesis in a number of patients undergoing intermittent haemodialysis. Serum folate levels in these and also in other uraemic patients not undergoing dialysis were low. These authors showed that haemodialysis could lower the serum folate in vitro and suggested but did not directly demonstrate that dialysis lowered the serum folate level in vivo. Subsequently Whitehead et al. (1968) and Mackenzie et al. (1969) reported the effects of haemodialysis on the serum folate level. MowAubray et al. (1965) found low serum folate levels and megaloblastic changes in the bone marrow in patients who had received transplant kidneys and azothiaprine therapy and siggested but did not show that removal of folate by dialysis may render the patient unduly sensitive to immunosuppressive drug therapy. Serum folate levels were measured by the microbiological assay with Lactobacillus casci described by Waters and Mollin (1961) . Red cell folate levels were measured by the method of Hoffbrand et al. (1966) . The normal range is from 160 to 640 mplg./ml. packed red cells. Serum vitamin-B12 levels were determined by the microbiological assay with Euglenza gracilis described by Anderson (1964) . The normal range is from 160 to 925 jtag./ml. Routine haematological methods were those described by Dacie and Lewis (1963 . Dialysis was performed through a Trocath with Dialaflex solutions, 2 litres per exchange. The fluid was left in the peritoneal cavity for from 10 to 20 minutes and the procedure repeated throughout the 24 hours until the plasma urea fell to about 100 mg./100 ml., after which dialysis was performed for 12 hours a day. Patients with acute renal failure were dialysed daily until the diuretic phase was established. Those with chronic renal failure were initially dialysed daily, and later were treated by intermittent peritoneal dialysis for 36 to 48 hours a week, with a low-protein diet between dialyses.
All patients on admission were given a 20-g. protein, lowsodium, high-calorie diet. This has an estimated folate content of 150-300 ,ug./day after cooking. A freer diet was allowed once the plasma urea had fallen, but restrictions were imposed again in chronic patients between intermittent dialyses.
Cases 1 to 5, 7, and 8 received ampicillin in a dose of 1 g./ day by intramuscular injection for most of their illness and Case 7 also had 1 g. of cloxacillin intramuscularly daily.
Results
Initial Serum Folate Levels.-The serum folate levels of the 25 normal control subjects ranged from 3 0 to 16 6 m'4g./ml.
(mean 7 7 mptg./ml.) (Fig. 1) . Of the seven patients in group 1, five had normal levels and two had levels above the upper limit of the normal control range (Fig. 1) (Fig. 2) , and in four patients with chronic renal failure who were dialysed (Fig. 3) . The Table summarizes pre-and postdialysis findings in all 17 patients who received dialysis. The serum folate rose with the blood urea before dialysis began in the two patients in whom repeat estimations were made (Fig. 2) .
In Case 7 it rose steadily from 4-2 to 10-5 m1Lg./ml. until a spontaneous diuresis was established, when it fell once more to 6-8 mjtg./ml. (Fig. 2) . The most striking finding, however, was that in all but one of the 17 patients dialysed the serum folate fell during dialysis (see Table) , the fall occurring after as little as one day of dialysis and being most rapid in the first few days of dialysis (Figs. 2 and 3) . The lower the initial serum folate level, the lower the level reached at the end of dialysis. In some patients the serum folate stabilized during dialysis but in others it continued to fall until dialysis was discontinued. After dialysis there was a rise in serum folate which could be detected after 24 hours. However, in all three patients with acute renal failure, and in two of three patients with chronic renal failure studied, the serum folate level had failed to reach the pre-dialysis level after from 1 to 20 days of follow-up. Table) . (Anderson, 1964) .
Hypersegmented Polymorphs.-These occurred in the peripheral blood films of three of the seven patients in group 1, 8 of the 10 in group 2, six of the eight in group 3, and five of the seven in group 4. There was no correlation between the presence of hypersegmented polymorphs and serum folate level, since hypersegmnented polymorphs were present in the films of 8 of the 10 patients with subnormal serum folate levels (80%) and of 14 of the 22 patients with normal serum folate levels (64 %). There was also no correlation between the presence of hypersegmented polymorphs and the length of history, blood urea, degree of anaemia, or serum-B12 level.
Discussion
The low initial serum and red cell folate levels in our patients with chronic renal failure who were severely ill (group 3) are similar to those found by Lasker et al. (1963) and Hampers et al. (1967) in patients with chronic renal failure. The explanation is probably a prolonged period of inadequate dietary intake of folate combined with losses of the vitamin due to vomiting. In patients with chronic renal failure who were less severely ill (group 4) or had been severely ill for only a matter of days (group 2) serum and red cell folate levels were almost invariably normal.
Serum folate levels in acute renal failure have not previously been reported. These were normal or above normal and the mean level was significantly raised. The explanation for these high levels is uncertain. Goresky et al. (1963) showed that, at least in the dog, plasma folate enters the glomerular filtrate and is reabsorbed by an active process by the renal tubules. Under normal conditions, however, some folate escapes absorption and enters the urine, the amount depending to a large extent on the dietary intake (Register and Sarett, 1951) . In patients with acute renal failure folate enters the plasma from the diet and, possibly in excessive amounts, from breaking down tissues, but cannot be excreted in the urine. In addition, bone marrow cell turnover may be depressed in uraemia, and thus the main pathway of folate utilization is diminished. In the face of these factors causing accumulation of folate in plasma, the liver, the principal site of folate storage, seems unable to remove folate rapidly enough from plasma to prevent the plasma level rising before kidney function and consequent folate excretion is re-established.
The present results clearly indicate that during peritoneal dialysis serum folate levels fall rapidly even in patients with initially subnormal levels, and Whitehead et al. (1968) suggested that haemodialysis also lowers the serum folate level. Folate is only loosely and non-specifically attached to protein in serum and presumably easily enters dialysis fluid. The slow rise of serum folate after dialysis suggests that the liver is unable to replenish plasma folate rapidly when this is acutely lowered. Indeed, it may be that the plasma folate is replenished after dialysis from the diet and not from liver stores at all.
Raised serm-B1 2 levels are well known to occur in renal failure (Matthews and Beckett, 1962 
several possible explanations, including decreased renal excretion of B12, liberation of B12 from damaged kidney tissue, or a rise in the serum-B 2-binding a-globulin in parallel with the rise in the serum levels of other a-globulins in renal disease. A rise in the serum-Bi2-binding a-globulin has been demonstrated in uraemia (Herbert, 1967 Introduction Though brain stem gliomas are more common in children than in adults, all age groups may be affected. They usually present as a progressive disorder, consisting of oculomotor palsies, defects of conjugate ocular deviation, and other scattered cranial nerve palsies. Pyramidal or cerebellar defects may appear early or may be long delayed, but signs of raised intracranial pressure are uncommon until the later stages. It is not widely appreciated, however, that these tumours may show a relapsing and remittent course, the remission sometimes being so complete and over such a long period that a diagnosis of multiple sclerosis may have been made, and regarded as correct until the final deterioration with headache, vomiting, coma, and respiratory failure brings the true diagnosis to light. Ford (1966) mentioned two children with brain stem glioma who had complete and spontaneous recovery and Sachs (1949) described a case in which the diplopia cleared up for several days before recurring. Apart from these reports, no other record of remission has been found in the literature.
The following four cases illustrate the course that some brain stem and para-brain-stem tumours take, and are recorded in the hope that they will emphasize the importance of keeping this diagnosis high among the differential possibilities when signs and symptoms continuously and repeatedly point to a lesion in this one part of the nervous system. Case 1 A woman aged 21 gave a five-month history of right-sided dysaesthesia followed by diplopia and right internal strabismus. This recovered completely, but was followed by a left internal strabismus. She had had left-sided ataxia for eight weeks, left deafness and tinnitus for three weeks, early morning headache with occasional vomiting for four weeks, and amenorrhoea for three months.
